Harvard spinout Nabla Bio nabs $11M for AI-driven antibody design
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportHarvard spinout Nabla Bio nabs $11M for AI-driven antibody design